pillbase.ru

Yargesa

Active substance: miglustat

miglustat

Centralised EU authorisationActive

Marketing holder: Piramal Critical Care B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 7
  • MIGLUSTAT
    CAPSULE · MIGLUSTAT 100 mg/1
    43975-310
    ANI Pharmaceuticals, Inc.
  • Miglustat
    CAPSULE · MIGLUSTAT 100 mg/1
    68475-204
    Navinta LLC
  • Miglustat
    CAPSULE · MIGLUSTAT 100 mg/1
    10148-201
    CoTherix, Inc.
  • Miglustat
    CAPSULE · MIGLUSTAT 100 mg/1
    70710-2039
    Zydus Pharmaceuticals USA Inc.
  • OPFOLDA
    CAPSULE · MIGLUSTAT 65 mg/1
    71904-300
    AMICUS THERAPEUTICS US, LLC
All products in this country (7)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-8f56-7499-bcc9-7c3478e16e36,01a12092-53b2-729f-a642-f7c102d974de,01a12093-3da4-7828-b5f4-d91247ba8bd2,01a12097-33eb-75b5-a605-c2c4603331b5,01a12098-8235-7238-87f6-dc9bdf25ca6b;count=7 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004016
Registration status
Active
ATC code
A16AX06
Sources
  • product · EMA · EMEA/H/C/004016 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004016 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004016 · Verified 2026-10-09